Fig. 1: LncRNA LINC00958 indicated an unfavorable prognosis for patients with BC.
From: m6A-induced LINC00958 promotes breast cancer tumorigenesis via the miR-378a-3p/YY1 axis
A The expression of LINC00958 was detected using RT-PCR in the enrolled patients with BC and control subjects. B The BC samples were divided into two groups (I/II and III/IV) according to clinical stage. RT-PCR was performed to detect LINC00958 expression. C RT-PCR indicates the levels of LINC00958 in normal mammary cells (MCF-10A) and BC cell lines (MDA-MB-231, MDA-MB-468, MCF-7, and BT-549). D Survival rate analysis reveals the unfavorable prognosis of BC clinical patients with higher LINC00958 expression. P < 0.05 was considered as significant.
